This compound is a chemical compound used as a pharmaceutical intermediate in the manufacturing of active pharmaceutical ingredients. It features an aromatic ether and a tertiary amine functional group.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 83015-25-2
Rac N-Methyl Atomoxetine Oxalate
Pharmaceutical intermediate for atomoxetine derivative
N-Nitroso-Atomoxetine
Nitrosamine impurity reference standard
N-[2-fluoro-6-(trifluoromethyl)benzyl]urea
Pharmaceutical intermediate
1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methylpyrimidine-2,4-dione
Pharmaceutical intermediate
5-bromo-1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
Pharmaceutical intermediate
1,1-Dimethylethyl N-[(1R)-2-[5-bromo-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]carbamate
pharmaceutical intermediate
N,N-dimethyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine
UCPQMRYBCNDVHU-UHFFFAOYSA-N
CC1=CC=CC=C1OC(CCN(C)C)C2=CC=CC=C2
—